[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 5, 2010

Tight Glycemic Control in Critically Ill Patients

JAMA. 2010;303(17):1694-1695. doi:10.1001/jama.2010.515

To the Editor: Recently published trials1,2 of tight glycemic control in critically ill patients have documented lack of treatment benefit and frequent severe hypoglycemia. The NICE-SUGAR trial raised the question of potential treatment-related harm and also documented significant hypoglycemia.3 The COIITSS Study4 evaluated intensive insulin therapy in critically ill patients with sepsis who were treated with glucocorticoids and reported a high incidence of hypoglycemia (16.4% vs 7.8% in the conventional treatment group) without apparent benefit. These large complex multicenter trials that evaluated insulin therapy during critical illness consistently demonstrated high rates of hypoglycemia with tight insulin therapy. However, they did not investigate the possibility of identifying patient subpopulations at increased risk for treatment-related hypoglycemia.

First Page Preview View Large
First page PDF preview
First page PDF preview
×